Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTangible Book ValueTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for NewGenIvf (NIVF) over the last 4 years, with Q3 2025 value amounting to $5198.1 billion.

  • NewGenIvf's Total Non-Current Liabilities changed N/A to $5198.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5198.1 billion, marking a year-over-year change of. This contributed to the annual value of $2339.1 billion for FY2024, which is 196601659202.13% up from last year.
  • Latest data reveals that NewGenIvf reported Total Non-Current Liabilities of $5198.1 billion as of Q3 2025.
  • NewGenIvf's Total Non-Current Liabilities' 5-year high stood at $5198.1 billion during Q3 2025, with a 5-year trough of $118979.0 in Q4 2023.
  • Over the past 4 years, NewGenIvf's median Total Non-Current Liabilities value was $3.7 million (recorded in 2025), while the average stood at $1507.4 billion.
  • In the last 5 years, NewGenIvf's Total Non-Current Liabilities plummeted by 5214.67% in 2023 and then surged by 196601659202.13% in 2024.
  • Quarter analysis of 4 years shows NewGenIvf's Total Non-Current Liabilities stood at $248633.0 in 2022, then crashed by 52.15% to $118979.0 in 2023, then soared by 1966016592.02% to $2339.1 billion in 2024, then skyrocketed by 122.22% to $5198.1 billion in 2025.
  • Its Total Non-Current Liabilities stands at $5198.1 billion for Q3 2025, versus $3.7 million for Q2 2025 and $2339.1 billion for Q4 2024.